FR2551085A1 - - Google Patents

Download PDF

Info

Publication number
FR2551085A1
FR2551085A1 FR8405576A FR8405576A FR2551085A1 FR 2551085 A1 FR2551085 A1 FR 2551085A1 FR 8405576 A FR8405576 A FR 8405576A FR 8405576 A FR8405576 A FR 8405576A FR 2551085 A1 FR2551085 A1 FR 2551085A1
Authority
FR
France
Prior art keywords
antibody
cell
prostate cancer
hybridoma
human prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR8405576A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58061917A external-priority patent/JPS59187796A/ja
Priority claimed from JP58061919A external-priority patent/JPS59188557A/ja
Priority claimed from JP6192283A external-priority patent/JPS59186923A/ja
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of FR2551085A1 publication Critical patent/FR2551085A1/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8405576A 1983-04-08 1984-04-09 Pending FR2551085A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58061917A JPS59187796A (ja) 1983-04-08 1983-04-08 抗ヒト前立腺癌抗体
JP58061919A JPS59188557A (ja) 1983-04-08 1983-04-08 ヒト前立腺癌の分類および同定用試薬
JP6192283A JPS59186923A (ja) 1983-04-08 1983-04-08 ヒト前立腺癌治療用薬剤

Publications (1)

Publication Number Publication Date
FR2551085A1 true FR2551085A1 (cg-RX-API-DMAC7.html) 1985-03-01

Family

ID=27297684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8405576A Pending FR2551085A1 (cg-RX-API-DMAC7.html) 1983-04-08 1984-04-09

Country Status (4)

Country Link
DE (1) DE3413341A1 (cg-RX-API-DMAC7.html)
FR (1) FR2551085A1 (cg-RX-API-DMAC7.html)
GB (1) GB2139645A (cg-RX-API-DMAC7.html)
SE (1) SE8401946L (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
JPH0249596A (ja) * 1988-08-09 1990-02-19 Masamichi Ueda ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001849A1 (en) * 1979-12-28 1981-07-09 Research Corp Purified human prostate antigen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
US4650756A (en) * 1981-08-31 1987-03-17 Sloan Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human renal cancer
NO169947C (no) * 1981-10-27 1992-08-26 Hybritech Inc Fremgangsmaate for fremstilling av et monoklonalt antistoff til et tumorassosiert antigen
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001849A1 (en) * 1979-12-28 1981-07-09 Research Corp Purified human prostate antigen

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 96, no. 21, 24 mai 1982, page 543, résumé no. 179218j, Columbus, Ohio, US; J.L. WARE et al.: "Production of monoclonal antibody alphaPro3 recognizing a human prostatic carcinoma antigen", & CANCER RES. 1982, 42(4), 1215-22 *
FEDERATION PROCEEDINGS, vol. 40, no. 6, 1981, page 1594, réf. 316; J.J. STARLING et al.: "Characterization of human prostate adenocarcinoma membrane antigens with monoclonal antibodies" *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 79, février 1982, pages 903-907; A.E. FRANKEL et al.: "Human prostate specific and shared differentiation antigens defined by monoclonal antibodies" *
UNLISTED DRUGS, vol. 34, no. 4, avril 1982, page 49, CA, US; "Human IgM monoclonal antibody produced by hybridoma of lymphocytes from patient with prostate tumor fused with murine NS-1 myeloma cells", & Fed. Proc. 41:1657 Abs, 01-03-1982 *

Also Published As

Publication number Publication date
SE8401946D0 (sv) 1984-04-06
GB8408988D0 (en) 1984-05-16
DE3413341A1 (de) 1984-11-22
GB2139645A (en) 1984-11-14
SE8401946L (sv) 1984-11-13

Similar Documents

Publication Publication Date Title
Hahn et al. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.
Hopper et al. Recongnition by guinea-pig peritoneal exudate cells of conformationally different states of the collagen molecule
EP0101039A2 (en) Monoclonal antibody, method of producing the same and use thereof
BE1000611A5 (fr) Anticorps monoclonaux et antigene du carcinome pulmonaire humain a cellules non petites et de certains autres carcinomes humains.
CN1920011A (zh) 识别增殖性人肝细胞的抗体、增殖性人肝细胞和功能性人肝细胞
EP0203089A1 (en) Monoclonal antibodies and their use
WO1983004104A1 (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
FR2551085A1 (cg-RX-API-DMAC7.html)
FR2543970A1 (fr) Anticorps vis-a-vis de champignons du genre aspergillus
FR2543969A1 (fr) Anticorps dirige contre les champignons du genre candida, hybridome et procede pour la preparation de cet anticorps, procede d'identification et/ou de classification des champignons du genre candida utilisant cet anticorps ou un de ses derives ou produits de restriction et medicament contre les candidoses contenant cet anticorps ou ses derives
FR2543971A1 (fr) Anticorps contre le cancer humain de la vessie
JPH04502363A (ja) 癌及びその他の疾病の診断としての基底膜成分の検出
JPH06153979A (ja) 魚類イリドウイルスに対するモノクローナル抗体並びに該抗体を製造するためのハイブリドーマ及び方法
JPS59188557A (ja) ヒト前立腺癌の分類および同定用試薬
EP0200745A1 (en) Monoclonal antibodies and their use
JPH05142228A (ja) ヒト前立腺癌の分類および同定用試薬
JPH03277295A (ja) 人体液中に存在する分子量７万〜３０万のコリンエステラーゼに反応するモノクローナル抗体
JPH02503513A (ja) ６４‐６９ｋＤの分子量を有する膵臓のβ細胞の抗原ファミリーに対するモノクローナル抗体の生産者であるハイブリドーマＣ１０Ｇ７株
JPH05203654A (ja) ヒト膀胱癌の分類および同定用試薬
JP3336033B2 (ja) 抗ヒト精液γ−グルタミルトランスペプチダーゼモノクローナル抗体、ハイブリドーマおよび前立腺疾患検出方法
JPS59186923A (ja) ヒト前立腺癌治療用薬剤
JPS59188558A (ja) ヒト膀胱癌の分類および同定用試薬
JPS61502631A (ja) モノクロ−ナル抗体およびその用途
EP0187801A1 (en) Monoclonal antibodies and their use
JPH05222098A (ja) カンジダ菌の分類および同定用試薬